Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinoma
- 1 October 2016
- journal article
- Published by Elsevier BV in Hepatobiliary & Pancreatic Diseases International
- Vol. 15 (5), 493-498
- https://doi.org/10.1016/s1499-3872(16)60133-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Doxorubicin‐eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2013
- Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomasJournal of Hepatology, 2011
- Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)Journal of Surgical Oncology, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applicationsClinica Chimica Acta; International Journal of Clinical Chemistry, 2008
- A Phase I/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting BeadClinical Gastroenterology and Hepatology, 2007
- Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokineticsJournal of Hepatology, 2007
- Hepatocellular carcinoma: Current management and future trendsGastroenterology, 2004
- Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinomaBritish Journal of Surgery, 2003
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaJournal of Hepatology, 2002